Stock Events

Stock Events

Rezolute 

$4.57
43
+$0.01+0.11% 16:33 Today

Statistics

Day High
4.62
Day Low
4.48
52W High
11.46
52W Low
1.07
Volume
269,696
Avg. Volume
1,705,906
Mkt Cap
439.57M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10SepExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-0.27
-0.23
-0.19
-0.15
Expected EPS
-0.14785
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-74.41MNet Income

Analyst Ratings

9.40Average Price Target
The highest estimate is 14.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy
80%
Hold
20%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RZLT. It's not an investment recommendation.
NVIDIA
16
NVDA
SoFi Technologies
13
SOFI
Microsoft
12
MSFT
Alphabet
12
GOOGL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Alnylam Pharmaceuticals
ALNY
Mkt Cap31.73B
Alnylam Pharmaceuticals, Inc. operates in the biopharmaceutical field focusing on RNAi therapeutics for the treatment of rare genetic diseases, competing in the same rare disease space as Rezolute.
Ionis Pharmaceuticals
IONS
Mkt Cap10.15B
Ionis Pharmaceuticals, Inc. develops RNA-targeted therapeutics, directly competing with Rezolute's approach to treating rare diseases through innovative therapies.
Viking Therapeutics
VKTX
Mkt Cap3.75B
Viking Therapeutics, Inc. is involved in the development of therapies for metabolic and endocrine disorders, directly competing with Rezolute's metabolic disease focus.
Seres Therapeutics
MCRB
Mkt Cap51.33M
Seres Therapeutics, Inc. is engaged in microbiome therapeutics for metabolic diseases, which places it in direct competition with Rezolute's metabolic disease treatments.
PTC Therapeutics
PTCT
Mkt Cap5.85B
PTC Therapeutics, Inc. focuses on the discovery and commercialization of novel medicines to treat rare disorders, directly competing with Rezolute in the rare disease market.
Sarepta Therapeutics
SRPT
Mkt Cap2.2B
Sarepta Therapeutics, Inc. specializes in the discovery and development of RNA-based therapeutics for the treatment of rare neuromuscular diseases, competing in the rare disease space alongside Rezolute.

About

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
Show more...
CEO
Nevan Charles Elam
Employees
71
Country
United States
ISIN
US76200L3096
WKN
000A2QEWP

Listings

F
DE
6HV1.F
BOATS
BOATS
RZLT.BOATS
STU
DE
6HV1.STU
MU
DE
6HV1.MU

0 Comments

Share your thoughts

FAQ

What is Rezolute stock price today?▼
The current price of RZLT is $4.57 USD — it has increased by +0.11% in the past 24 hours. Watch Rezolute stock price performance more closely on the chart.
What is Rezolute stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Rezolute stocks are traded under the ticker RZLT.
Is Rezolute stock price growing?▼
RZLT stock has fallen by -8.23% compared to the previous week, the month change is a -6.92% fall, over the last year Rezolute has showed a -36.88% decrease.
What is Rezolute market cap?▼
Today Rezolute has the market capitalization of 439.57M
When is the next Rezolute earnings date?▼
Rezolute is going to release the next earnings report on September 10, 2026.
What were Rezolute earnings last quarter?▼
RZLT earnings for the last quarter are -0.16 USD per share, whereas the estimation was -0.18 USD resulting in a +11.5% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Rezolute revenue for the last year?▼
Rezolute revenue for the last year amounts to 0 USD.
What is Rezolute net income for the last year?▼
RZLT net income for the last year is -74.41M USD.
How many employees does Rezolute have?▼
As of September 03, 2026, the company has 71 employees.
In which sector is Rezolute located?▼
Rezolute operates in the Health & Wellness sector.
When did Rezolute complete a stock split?▼
The last stock split for Rezolute was on October 13, 2020 with a ratio of 1:50.
Where is Rezolute headquartered?▼
Rezolute is headquartered in REDWOOD CITY, United States.